Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis (Q40191340)

18 September 2017

Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis (English)

1 reference

familial Mediterranean fever

18 September 2017

1 reference

Z Birsin Özçakar

1

1 reference

18 September 2017

Semanur Özdel

2

1 reference

18 September 2017

Songül Yılmaz

3

1 reference

18 September 2017

E Didem Kurt-Şükür

4

1 reference

18 September 2017

Mesiha Ekim

5

1 reference

18 September 2017

Fatoş Yalçınkaya

6

1 reference

18 September 2017

13 September 2014

1 reference

18 September 2017

Clinical Rheumatology

1 reference

18 September 2017

35

1 reference

18 September 2017

441-446

1 reference

18 September 2017

2

1 reference

Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever.

18 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2772-2

Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2772-2

Efficacy and safety of biologic treatments in Familial Mediterranean Fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2772-2

Infliximab therapy for familial Mediterranean fever-related amyloidosis: case series with long term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2772-2

Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2772-2

Treatment of familial Mediterranean fever with anakinra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2772-2

Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2772-2

Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2772-2

Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2772-2

A new set of criteria for the diagnosis of familial Mediterranean fever in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2772-2

Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2772-2

Mutation frequency of Familial Mediterranean Fever and evidence for a high carrier rate in the Turkish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2772-2

Ancient Missense Mutations in a New Member of the RoRet Gene Family Are Likely to Cause Familial Mediterranean Fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2772-2

A candidate gene for familial Mediterranean fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2772-2

Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2772-2

Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2772-2

The changing face of familial Mediterranean fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2772-2

Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2772-2

Long-term colchicine treatment in children with familial mediterranean fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2772-2

Incomplete response to colchicine in M694V homozygote FMF patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2772-2

Treating inflammation by blocking interleukin-1 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2772-2

21 January 2018

[The periodic disease]

1 reference

12 December 2020

Anakinra suppresses familial Mediterranean fever crises in a colchicine-resistant patient

1 reference

12 December 2020

Colchicine for familial Mediterranean fever

1 reference

12 December 2020

Familial Mediterranean fever: clinical, molecular and management advancements

1 reference

12 December 2020

Vasculitis in familial Mediterranean fever

1 reference

12 December 2020

Familial Mediterranean fever - renal involvement by diseases other than amyloid

1 reference

12 December 2020

Familial Mediterranean fever in small children in Turkey

1 reference

12 December 2020

Can colchicine response be predicted in familial Mediterranean fever patients?

1 reference

12 December 2020

10.1007/S10067-014-2772-2

Identifiers

DOI

1 reference

18 September 2017

1 reference